The effects of tylosin-related macrolide antibiotics were examined in cell-free protein synthesis (using a coupled transcription-translation system derived from Streptomyces lividans) and against whole cells of that organism. Anti-ribosomal potency was determined primarily by the number and nature of the glycosyl substituents, and was not significantly influenced by lactone ring oxidation or sugar methylation. In contrast, uptake of the drugs into S. lividans was influenced, either positively or negatively, by each of these structural parameters. The presence of erm type I or erm type II resistance genes in S. lividans markedly affected the resistance phenotype and studies involving ribosomes from such strains revealed differences in macrolide activity that were not otherwise apparent.
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Macrolide antibiotics bind to the 50S subunit of the previously been examined against polyA-directed synbacterial ribosome, thereby inhibiting protein synthesis1^thesis of polylysine2). Alternatively, the anti-ribosomal Since cell-free protein-synthesising systems programmed activities of macrolides have been examined by following by polyU are relatively insensitive to certain macrolides their respective abilities to competefor ribosomal bind-(such as erythromycin), the action of such drugs has ing sites with radiolabelled erythromycin3~5) or leuco- THE JOURNAL OF ANTIBIOTICS mycin6). Assumptions inherent in such studies were that the various macrolides were competing for the same target site(s) and that ribosomal binding affinity measured in that way was directly related to the efficiency of ribosomal inhibition. Here, the ability of tylosin-related macrolides ( Fig. 1 ) to inhibit ribosomal function has been measured directly in a coupled transcriptiontranslation system, the closest cell-free model for intracellular protein synthesis. Macrolides do not inhibit RNA synthesis, therefore this assay system could be used specifically to monitor translation. Since macrolides are mainly active against Gram-positive bacteria, coupled transcription-translation systems were prepared using fractionated extracts of Streptomyceslividans1^: The strain used (OS456) had been specifically engineered to be macrolide-sensitive by insertional inactivation of a tandem pair of indigenous resistance genes9 Cell-free Protein Synthesis A coupled transcription-translation system was used to assay cell-free protein synthesis. Salt-washed ribosomes were prepared from S. lividans OS456 and from the tlrD+ and ermE+strains, and used together with protein synthesis initiation factors plus postribosomal 100,000 x g supernatant (S100), both from strain OS456. These materials were prepared as described elsewhere (Thompson et al, 1984; Calcutt and Cundliffe, 1989) . Plasmid DNA(pUCl 8; prepared using a Qiagen column)
was added as the template for transcription (the SI00 contains RNA polymerase), and translation of the resultant mRNA was measured as the incorporation of [35S]methionine into newly synthesized protein.
Results and Discussion Cell-free Protein Synthesis
Monoglycosidic macrolides, with mycaminose attached at C5-OH of the lactone ring, displayed low levels of activity against ribosomes from S. lividans OS456 or the tlrD+ strain (erm type I), with no detectable inhibition of ribosomes from the ermE+ (erm type II) strain (Table 1) . Although these levels of anti-ribosomal activity were low, their significance was evident from the respective MIC values ( Table 2) ; effects of similar magnitude were also observed previously with other MLSantibiotics9).
Macrolides containing a neutral sugar in addition to mycaminosewere dramatically moreactive than the monoglycosides against control or erm-I ribosomes, and even erm-II particles were sensitive to the triglycosides, albeit at somewhat higher concentrations. Since the diglycoside, demycinosyl-tylosin, and the bis-glycoside, demycarosyl-tylosin (desmycosin), displayed similar activities, each of the two neutral sugars contributed to enhanced potency, which was even further enhanced by their combined presence. When other macrolides (i.e. not of the tylosin series) were examined under similar conditions, differences in their antiribosomal activities were also attributed to the relative disposition of glycosidic residues around the polyketide lactones and not, for example, to the relative sizes of the lactone rings9). None of the other structural variations (10) 35 (10) 55 (10) a Calculated for 40minutes time points. The synthesis rate was approximately linear over this period. Drug concentrations are in jug/ml. All other components of the coupled transcription-translation system were derived from control strain OS456.
OMT: 0-mycaminosyl-tylonolide;
DMT: demycinosyltylosin.
assessed here produced anti-ribosomal effects as dramatic as those attributable to the patterns of glycosylation. Clearly, the action of macrolide antibiotics at the level of the ribosome is determined primarily by the number and nature of their glycosyl substituents, as first suggested by others2). Antibacterial Activities of Tylosin-related Macrolides Tylosin was significantly morepotent than macrocin and at least 50-fold more potent than Odemethylmacrocin against the control and erm type I strains, revealing the importance of methylation of the deoxyallose moiety, especially at 2"'-OH. A less dramatic, but still important, variable was the level of oxidation at C20; an aldehyde group at that site (as in tylosin or 23-deoxy-OMT) conferred greater potency than a primary alcohol (as in relomycin or 20-dihydro, 23-deoxy-OMT,respectively). A hydroxyl group at C23 was also disadvantageous (e.g. OMTwas less potent than 23-deoxy-OMT) but substitution of the C23-OH with mycinose (converting OMT to desmycosin) significantly enhanced the activity (an effect seen most clearly with the erm type I strain). Demethyl-lactenocin, which differs from desmycosin in containing deoxyallose rather than mycinose, was not available to us. However, the pronounced effects of 2'"-. and 3"'-6>-methylation described OCT. 1996 above suggest that demethyl-lactenocin would have been muchless potent than desmycosin against S. lividans, as seen previously with Gram-positive cocci1 3).
Ribosomal Binding and Drug Uptake Structural changes in drug molecules that affect their uptake and/or intracellular accumulation mayhave no effects at all on ribosomal binding affinity, but the converse situation is more interesting. Bacterial cells or mycelial units contain tens of thousands of ribosomes, which occupy a significant fraction of the intracellular volume and afford a potential "sink" effect that could promote the uptake of anti-ribosomal drugs. Such considerations do not apply to less abundant drug-targets, such as RNApolymerase, DNAgyrase etc. It is therefore possible that changes in drug molecules that change their affinity for ribosomes might have consequential effects on their uptake. Moreover, small changes in ribosomal affinity could easily lead to large changes in uptake. This point is best made by comparing the effects of specific drugs on strains that differ only in the state of their ribosomes. For example, a barely detectable reduction in ribosomal affinity (resulting from the erm type I mechanism) can cause the MICvalue to increase dramatically, as seen here (Table 1) 
Contribution of Glycosyl Moieties to Macrolide Activity
Biological activity is conferred upon tylosin-related macrolides by substitution of the amino sugar, mycaminose, at C5-OH of the otherwise inert polyketide lactone, tylactone. However, the consequences of further glycosylation with neutral sugars have been variously interpreted. Whenassayed against Gram-positive cocci, the presence ofmycinose and/or mycarose had little effect on antibacterial activity, so that tylosin, desmycosin, DMTand OMTdisplayed similar MIC values13*. In contrast, desmycosin was less active than tylosin against
Bacillus subtilis but was more active in a ribosomal binding assay, suggesting that the mycarose moiety might be more important for uptake or intracellular accumulation of tylosin than for drug-target interaction5*. In our hands, the addition of mycarose to OMT(generating DMT) raised the MIC against S. lividans OS456 and the erm type I strain, despite the much greater activity of DMT against their ribosomes. Similarly, tylosin and desmycosin gave similar MICvalues with the erm type II strain, although tylosin was vastly more potent than desmycosin against erm-II ribosomes. These data imply a marked negative influence of the mycarose moiety on drug uptake and/or accumulation in S. lividans. They also reveal a positive influence of the mycarose moiety on anti-ribosomal activity that is most readily seen with the refractory erm-II ribosomes. It was also proposed6) that the mycinose moiety aids uptake of tylosin-related macrolides rather than antiribosomal affinity, since OMTwas more active than desmycosin against Escherichia coli ribosomes, but not against whole cells of various strains. In our hands, desmycosin was vastly more potent than OMTagainst control or erm-I ribosomes from S. lividans and tylosin was muchmore active than DMTagainst erm-II ribosomes, revealing an important role for the mycinose moiety in ribosomal binding. Our data also support the proposed involvement of the mycinose moiety in drug uptake, since tylosin and DMTwere both extremely active against control or erm-I ribosomes, whereas the intact organisms (especially the erm type I strain) were muchmore sensitive to tylosin. Changing the Oxidation Level at C20 Enhanced antibacterial potencies of tylosin compared with relomycin, and 23-deoxy-OMT compared with 20-dihydro, 23-deoxy-OMT (Table 2) , while not as pronounced as those seen with other organisms6'13), were not associated with enhanced anti-ribosomal activities 1047 (Table 1) . These data are compatible with previous reports5' 6) that the primary influence of the C20 aldehyde group (as opposed to a primary alcohol) is at the level of drug uptake or accumulation rather than ribosomal binding.
Substitution at C23 Here and in previous reports6'13), 23-deoxy-OMT was significantly more potent than OMT against intact bacteria. However, the anti-ribosomal activities of the two drugs were quite similar (present work; also6)). The simplest explanation of these results is that hydroxylation at C23 impairs the uptake and/or intracellular accumulation of macrolide monoglycosides, with little or no effect on their anti-ribosomal activities.
As discussed earlier, glycosylation at C23-OH reduces activity even further, unless followed by 2////3///-O-methylation13).
Interestingly, the negative influence of C23-OHwas not apparent with diglycosidic macrolides; DMTand 23-demycinosyloxy-tylosin displayed similar antibacterial activities14).
2"'//3/"-Methylation
Prior to the present work, the effects of this parameter on anti-ribosomal activity had not been investigated, although the contribution to antibacterial activity has long been known13). Since methylation of the 2'"-and 3"'-OH groups made virtually no contribution to antiribosomal potency (compare data obtained with Odemethylmacrocin and tylosin in Table 1 ), the primary effect must be to enhance drug uptake.
Ribosomal Binding and Inhibition of Protein Synthesis
Earlier studies focused on the abilities of macrolides to compete for ribosomal binding sites with radiolabelled erythromycin3~5) or leucomycin6). Here, the inhibition of ribosomal function has been measured directly in a coupled transcription-translation system. Such differences in methodology and the use of different strains presumably underly variance between the respective results. For example, OMTand 23-deoxy-OMT competed as efficiently as tylosin in binding studies involving radiolabelled leucomycin and E. coli ribosomes6), whereas tylosin was at least 2 orders of magnitude more potent than OMTor 23-deoxy-OMT against protein synthesis in extracts of S. lividans (Table 1) . Another feature of the present work was the use of erm type strains. In addition to documenting the resistance phenotypes of such organisms with respect to the tylosin series of macrolides, the use of erm-II ribosomes in particular amplified or revealed differences in inhibitory actions that were otherwise not apparent. For example, the dramatic anti-ribosomal superiority of tylosin and the other triglycosides over DMTand desmycosin was not obvious with wild type ribosomes. Such differences were not necessarily confined to the ribosomal affinities of the drugs, since the use of modified ribosomes can also reveal subtle differences in modes of action, as demonstrated elsewhere1 5).
